ClinConnect ClinConnect Logo
Search / Trial NCT04087798

Controlling Hypertension Through Education and Coaching in Kidney Disease

Launched by UNIVERSITY OF MICHIGAN · Sep 10, 2019

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

Patients that meet eligibility criteria and are seen in a clinic assigned to the control group will be given a Control-Encounter Decision Intervention (Control-EDI) about kidney disease in general (not tailored to the patient) by their primary care provider. Eligible patients that agree to participate and give consent will complete enrollment, 1, 6, and 12 month follow-up visits.

Eligible patients that are seen in a clinic assigned to the intervention group will be given a personalized Intervention-EDI by their primary care provider. Following this, eligible patients that agree to particip...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of CKD stage 3, 4, or 5 documented in medical record
  • Aware of CKD diagnosis
  • Has diagnosis of hypertension documented in medical record and most recent Blood Pressure (BP) within the last year meets criteria of uncontrolled hypertension (≥140 mmHg, and/or a diastolic blood pressure ≥90 mmHg noted in an ambulatory care setting within the past one year)
  • Estimated glomerular filtration rate (eGFR) of \<60 within the last 18 months documented in the medical record
  • Exclusion Criteria:
  • Currently on dialysis permanently (i.e. are considered "end-stage renal disease" and receiving dialysis)
  • Previous kidney transplant
  • Pregnant (indicated by medical record or if patient self-identifies as pregnant)
  • Has cognitive, language, or vision impairment(s) that would prohibit participating in education, taking surveys, or participating in coaching activities
  • Has terminal illness

About University Of Michigan

The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.

Locations

Ann Arbor, Michigan, United States

Ann Arbor, Michigan, United States

Brighton, Michigan, United States

Chelsea, Michigan, United States

Detroit, Michigan, United States

Detroit, Michigan, United States

Dexter, Michigan, United States

Livonia, Michigan, United States

Northville, Michigan, United States

Ypsilanti, Michigan, United States

Canton, Michigan, United States

Patients applied

0 patients applied

Trial Officials

Julie Wright, MD

Principal Investigator

University of Michigan

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials